Recent Finacing
Recent Raise
QurAlis is a Cambridge-based clinical-stage biotech developing precision therapeutics for genetically defined ALS and FTD using patient-derived neuronal networks, proprietary stem-cell platforms, biomarkers, and structure-based drug design.
